RENO,
Nevada and CARVER, Massachusetts October 6, 2006
– Decas Botanical Synergies (DBS), a subsidiary of Decas
Cranberry Products, Inc., today announced the results of a
recent clinical study using PACran™ whole cranberry powder
standardized to cranberry proanthocyanidins (PACs). The
double blind 90-day study examined the effect of
supplementation with PACran on women volunteers confirmed
with the presence of E.
coli in the culture of urine samples. At the end
of the 90-day treatment period, a daily oral dose of 500 mg
of PACran was shown to significantly reduce the presence of
E. coli and
can be advocated in the prevention of urinary tract
infections. PACran is the first and only clinically
supported and PAC-standardized cranberry ingredient.
Urinary
tract infections (UTIs) are a serious health problem
affecting millions of people each year. Most infections
arise from one type of bacteria,
Escherichia coli (E. coli)
and are the second most common
type of infection in
the body. UTIs account for about 11 million doctor visits
each year and an estimated US health care cost of more than
$1 billion.
“PACran not
only guarantees the amount of active compound responsible
for the prevention of urinary tract infections but we now
have shown it to be clinically effective in a low dose,”
said Doug Klaiber, DBS general manager. “We continue to
invest our resources in PACran which has set a new standard
for all cranberry products on the market.”
P.L. Thomas
& Co., Inc., is DBS’ exclusive distributor and marketing
partner for the U.S.A. Paul Flowerman, PLT’s president,
states: “PACran is a revolutionary cranberry development
for which strong science and brand support will be provided.
We believe PACran offers formulators of women’s health
products a new high quality brand that will be embraced by
consumers.”
Learn more
about PACran and the importance of proanthocyanidins (PACs)
on the newly launched web site
http://www.PACran.com.
About Decas Botanical
Synergies (DBS)
Headquartered in Carver, Massachusetts, Decas Botanical
Synergies (DBS), a subsidiary of Decas Cranberry Products,
Inc., is a developer, manufacturer and marketer of
proprietary, value-added fruit-derived ingredients for the
dietary supplement, functional foods, animal feed and
nutrition, personal care and cosmetics, and oral health
industries. Specializing in cranberries, DBS’
FruitaceuticalÔ
products are rich in natural bioflavonoid complexes, which
provide manufacturers with powerful antioxidant,
antimicrobial and nutritional properties, and a natural
colorant for a broad variety of applications. Decas
powders, extracts and oils offer cost-effective and natural
options to enhance the taste, color, function and
nutritional content of products.
